Human CD196/CCR6 HEK293T Stable Cell Line

Introduction

Human CD196/CCR6 HEK293T Stable Cell Line is a valuable tool for studying the structure, activity, and potential therapeutic applications of the human chemokine receptor CD196, also known as CCR6. This stable cell line is derived from HEK293T cells, a commonly used cell line in biomedical research, and has been genetically modified to stably express human CD196. In this article, we will provide a detailed description of the structure and function of CD196, the activity of the stable cell line, and its potential applications in research and therapeutics.

Structure of CD196

CD196 is a G-protein coupled receptor (GPCR) that is primarily expressed on the surface of immune cells, including T cells, B cells, and dendritic cells. It is composed of 7 transmembrane domains, with an extracellular N-terminus and an intracellular C-terminus. The extracellular region contains several conserved cysteine residues that form disulfide bonds to maintain the receptor’s structure. The intracellular region contains sites for G-protein coupling and signaling, as well as phosphorylation sites that regulate receptor activity.

Activity of CD196

CD196 is a receptor for the chemokine CCL20, also known as macrophage inflammatory protein-3 alpha (MIP-3α). Upon binding to CCL20, CD196 triggers a signaling cascade that leads to the activation of various immune cells and the recruitment of these cells to sites of inflammation. This chemotactic activity is crucial for the proper functioning of the immune system and plays a role in the pathogenesis of various diseases, including autoimmune disorders and cancer.

Flow Cytometry Analysis

Flow cytometry is a powerful technique for analyzing the expression and activity of cell surface receptors such as CD196. The Human CD196/CCR6 HEK293T Stable Cell Line can be used in flow cytometry experiments to study the binding and signaling of CCL20 to CD196. By labeling the stable cell line with fluorescent antibodies against CD196, researchers can measure the level of receptor expression and assess its activation upon stimulation with CCL20.

Potential Applications

The Human CD196/CCR6 HEK293T Stable Cell Line has various potential applications in research and therapeutics. As a model cell line for CD196, it can be used to study the structure and function of the receptor, as well as its interactions with CCL20 and other ligands. Furthermore, the stable cell line can be used to screen for potential drugs or antibodies that modulate CD196 activity, which could have therapeutic potential for diseases involving dysregulated immune cell recruitment.

Therapeutic Target

CD196 has been identified as a potential therapeutic target for various diseases, including inflammatory bowel disease, rheumatoid arthritis, and certain types of cancer. The Human CD196/CCR6 HEK293T Stable Cell Line can be used in drug discovery and development efforts to identify novel compounds that can inhibit or enhance CD196 activity. By studying the effects of these compounds on the stable cell line, researchers can gain valuable insights into the potential therapeutic benefits of targeting CD196.

Conclusion

In summary, the Human CD196/CCR6 HEK293T Stable Cell Line is a valuable tool for studying the structure, activity, and potential therapeutic applications of CD196. Its use in flow cytometry experiments allows for the analysis of CD196 expression and activity, while its potential applications in research and therapeutics make it a valuable asset in the study of immune-related diseases. With the growing interest in CD196 as a therapeutic target, the Human CD196/CCR6 HEK293T Stable Cell Line will continue to play a crucial role in advancing our understanding of this important chemokine receptor.